Abstract
We tested antimicrobial susceptibility of retrospective collection of clinical strains group С and G streptococci (69 strains including 58 strains of Streptococcus dysgalactiae subspecies equisimilis and 11 strains of Streptococcus anginosus). Susceptibility testing was performed by discdiffusion method according to Russian national guidelines. Penicillins, as well as cephalosporins and vancomycin were active against all tested strains. Susceptibility of S. anginosus and S. dysgalactiae subspecies equisimilis to macrolides was from 5.8% to 26.1%, to tetracyclines – from 10.1% to 18.8%, respectively.
-
1.
Fischetti V.A., et al. 2000. Gram-positive pathogens. ASM Press, Washington, D.C.
-
2.
Lindahl G., Stalhammar-Carlemalm M., Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Reviews 2005; 18(1):102-27.
-
3.
Rausch J., Foca M. Necrotizing fasciitis in a pediatric patient caused by Lancefield group G streptococcus: case report and brief review of the literature. Case Report Med 2011;:671365.
-
4.
Kittang B.R., Langeland N., Skrede S., Mylvaganam H. Two unusual cases of severe soft tissue infection caused by Streptococcus dysgalactiae subsp. equisimilis. J Clin Microbiol 2010, 48(4):1484-7.
-
5.
Suemori S., Sawada A,, Komori S., Mochizuki K., Ohkusu K., Takemura H. Case of endogenous endophthalmitis caused by Streptococcus equisimilis. Clin Ophthalmol 2010, 4:917-8.
-
6.
Reissmann S., Friedrichs C., Rajkumari R., et al. Contribution of Streptococcus anginosus to infections caused by groups C and G streptococci, Southern India. Emerg Infect Dis 2010, 16(4):656-63.
-
7.
Hashikawa S., Iinuma Y., Furushita M., et al., Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 2004, 42(1):186-92.
-
8.
Timoney J. F. The pathogenic equine streptococci. Vet Res 2004, 35:397-409.
-
9.
Woo P.C., Fung A.M., Lau S.K., Wong S.S., Yuen K.Y. Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal rna gene sequencing. J Clin Microbiol 2001, 39(9):3147-55.
-
10.
Savini V., Catavitello C., Talia M., et al. -Lactam failure in treatment of two group G Streptococcus dysgalactiae subsp. equisimilis pharyngitis patients. J Clin Microbiol 2008, 46(2):814-6.
-
11.
Maeda Y., Goldsmith C.E., Coulter W.A., et al. Comparison of minimum inhibitory concentration by broth microdilution testing versus standard disc diffusion testing in the detection of penicillin, erythromycin and ciprofloxacin resistance in viridans group streptococci. J Med Microbiol 2011, 60(12):1782-6.
-
12.
Maeda Y., Elborn J.S., Parkins M.D., et al. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF). J Cyst Fibros 2011, 10(2):133-9.
-
13.
Yang Q., Xu Y., Chen M., et al. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Diagn Microbiol Infect Dis 2012, 73(2):187-91.
-
14.
Ильясов Ю.Ю., Biswas I., Тотолян А.А., Дмитриев А.В. Метод дифференциальной ПЦР-диагностики стрептококков групп С и G. Клин лабор диагностика 2011, 2:40-3.
-
15.
Козлов Р.С., Сивая О.В., Шпынев К.В., и соавт. Антибиотикорезистентность S. pyogenes в России. Клин микробиол антимикроб химиотер 2005; 7(2):154- 66.
-
16.
Biedenbach D.J., Toleman M.A., Walsh T.R., Jones R.N. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 2006, 55(2):119-27.
-
17.
Lloyd C.A., Jacob S.E., Menon T. Antibiotic resistant beta-hemolytic streptococci. Indian J Pediatr 2007, 74(12):1077-80.
-
18.
Petrovski K.R., Laven R.A., Lopez-Villalobos N. A descriptive analysis of the antimicrobial susceptibility of mastitis-causing bacteria isolated from samples submitted to commercial diagnostic laboratories in New Zealand (2003-2006). N Z Vet J 2011, 59(2):59-66.